Kiyotaka Yoh

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

Kiyotaka Yoh

Mar 5, 2025, 16:21 | Science

Eric Singhi: Phase 1a study of zongertinib in metastatic solid tumors with HER2 alterations

Eric Singhi, Assistant Professor in the Department of General Oncology at The University of Texas…

Jan 8, 2025, 14:07 | Science

Rami Manochakian: Results of TROPION/Lung05 Phase 2 trial are out

Rami Manochakian shared a post on X: "Hot off the press. Just published in the Journal…

Dec 20, 2024, 14:12 | Science

Yuji Uehara: Resistance to osimertinib in EGFR-mutated LUAD

Yuji Uehara, Medical Oncologist, National Cancer Center, Japan, shared a post on X about a recent…

Aug 27, 2024, 21:09 | Insight

5 papers about lung cancer suggested by Stephen Liu

Stephen Liu, Head of Developmental Therapeutics at Georgetown Lombardi Comprehensive Cancer Center, shared a few…

All: 4 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023